Henry D. Diamond

2.6k total citations · 2 hit papers
36 papers, 2.0k citations indexed

About

Henry D. Diamond is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Henry D. Diamond has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Henry D. Diamond's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Henry D. Diamond is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Henry D. Diamond collaborates with scholars based in United States. Henry D. Diamond's co-authors include Lloyd F. Craver, Saul A. Rosenberg, Robert S. Sherman, John M. Richmond, Daniel G. Miller, Ruven Levitan, David Schottenfeld, Abraham M. Lilienfeld, Harold W. Dargeon and Stephen A. Rosenberg and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Henry D. Diamond

33 papers receiving 1.6k citations

Hit Papers

LYMPHOSARCOMA: A REVIEW OF 1269 CASES 1961 2026 1982 2004 1961 1962 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. LYMPHOSARCOMA: A REVIEW OF 1269 CASES
    1961 798 citations Saul A. Rosenberg, Henry D. Diamond et al. Medicine profile →
  2. Renal lesions associated with malignant lymphomas
    1962 298 citations Henry D. Diamond, Lloyd F. Craver et al. The American Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry D. Diamond United States 18 1.0k 562 464 443 358 36 2.0k
Lloyd F. Craver United States 15 880 0.9× 511 0.9× 424 0.9× 430 1.0× 325 0.9× 30 2.1k
K.A. MacLennan United Kingdom 21 1.1k 1.0× 552 1.0× 383 0.8× 313 0.7× 326 0.9× 45 1.6k
J. O. Armitage United States 20 1.4k 1.4× 1.1k 1.9× 259 0.6× 240 0.5× 613 1.7× 54 2.5k
Peter Bucsky Germany 21 531 0.5× 596 1.1× 353 0.8× 1.0k 2.3× 260 0.7× 59 2.8k
H Rubie France 28 590 0.6× 649 1.2× 353 0.8× 312 0.7× 270 0.8× 75 2.3k
G Farrer-Brown United States 16 506 0.5× 250 0.4× 183 0.4× 193 0.4× 224 0.6× 40 1.3k
Milton H. Donaldson United States 26 346 0.3× 529 0.9× 1.1k 2.3× 496 1.1× 160 0.4× 62 2.3k
Jillian R. Mann United Kingdom 27 263 0.3× 390 0.7× 361 0.8× 905 2.0× 472 1.3× 82 2.2k
Bertha A. Bouroncle United States 21 515 0.5× 266 0.5× 142 0.3× 238 0.5× 909 2.5× 46 1.8k
Ruth Heyn United States 23 585 0.6× 859 1.5× 1.7k 3.7× 716 1.6× 91 0.3× 38 2.5k

Countries citing papers authored by Henry D. Diamond

Since Specialization
Citations

This map shows the geographic impact of Henry D. Diamond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry D. Diamond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry D. Diamond more than expected).

Fields of papers citing papers by Henry D. Diamond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry D. Diamond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry D. Diamond. The network helps show where Henry D. Diamond may publish in the future.

Co-authorship network of co-authors of Henry D. Diamond

This figure shows the co-authorship network connecting the top 25 collaborators of Henry D. Diamond. A scholar is included among the top collaborators of Henry D. Diamond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry D. Diamond. Henry D. Diamond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Daniel G., et al.. (1963). Vincristine in the treatment of lymphomas and leukemias.. PubMed. 23. 613–21. 74 indexed citations
2.
Diamond, Henry D., et al.. (1962). γ-Globulin Metabolism in Chronic Lymphocytic Leukemia<xref ref-type="fn" rid="fn1">2</xref>. JNCI Journal of the National Cancer Institute. 29. 443–53. 3 indexed citations
3.
Levitan, Ruven, Henry D. Diamond, & Lloyd F. Craver. (1961). The liver in Hodgkin's disease. Gut. 2(1). 60–71. 36 indexed citations
4.
Rosenberg, Saul A., et al.. (1961). LYMPHOSARCOMA: A REVIEW OF 1269 CASES. Medicine. 40(1). 31–84. 798 indexed citations breakdown →
5.
Diamond, Henry D. & Daniel G. Miller. (1961). Chronic Lymphocytic Leukemia. Medical Clinics of North America. 45(3). 601–611. 6 indexed citations
6.
Levitan, Ruven, Henry D. Diamond, & Lloyd F. Craver. (1961). Jaundice in Hodgkin's disease. The American Journal of Medicine. 30(1). 99–111. 54 indexed citations
7.
Rosenberg, Stephen A., et al.. (1960). LYMPHOSARCOMA: THE EFFECTS OF THERAPY AND SURVIVAL IN 1,269 PATIENTS IN A REVIEW OF 30 YEARS' EXPERIENCE. Annals of Internal Medicine. 53(5). 877–897. 39 indexed citations
8.
Levitan, Ruven, Henry D. Diamond, & Lloyd F. Craver. (1959). Esophageal varices in Hodgkin's disease involving the liver. The American Journal of Medicine. 27(1). 137–143. 12 indexed citations
9.
Diamond, Henry D.. (1959). Treatment of Leukemia. CA A Cancer Journal for Clinicians. 9(2). 54–59. 1 indexed citations
10.
Diamond, Henry D., et al.. (1959). HODGKIN??S DISEASE ASSOCIATED WITH OTHER MALIGNANT TUMORS AND CERTAIN NONNEOPLASTIC DISEASES. The American Journal of the Medical Sciences. 238(3). 327–335. 94 indexed citations
11.
Levitan, Ruven, et al.. (1959). ABO Blood Groups in Hodgkin’s Disease. Acta Haematologica. 22(1). 12–19. 5 indexed citations
12.
Miller, Daniel G., Henry D. Diamond, & Lloyd F. Craver. (1959). The Clinical Use of Chlorambucil. New England Journal of Medicine. 261(11). 525–535. 30 indexed citations
13.
Rosenberg, Saul A., Henry D. Diamond, Harold W. Dargeon, & Lloyd F. Craver. (1958). Lymphosarcoma in Childhood. New England Journal of Medicine. 259(11). 505–512. 93 indexed citations
14.
Diamond, Henry D.. (1958). The lymphomas. Disease-a-Month. 4(1). 38–60. 1 indexed citations
15.
Diamond, Henry D., Lloyd F. Craver, & Helen Q. Woodard. (1957). Radioactive phosphorus.III. In the treatment of malignant lymphomas, plasma-cell myeloma, Ewing's sarcoma, and osteogenic sarcoma. Cancer. 10(1). 143–150. 5 indexed citations
16.
Diamond, Henry D.. (1957). Hodgkin's disease: neurologic sequelae.. PubMed. 54(10). 945–56. 10 indexed citations
17.
Southam, Chester M., Henry D. Diamond, & Lloyd F. Craver. (1956). Pregnancy during hodgkin's disease. Cancer. 9(6). 1141–1146. 11 indexed citations
18.
Diamond, Henry D., et al.. (1955). Hodgkin's disease and allergy. Cancer. 8(1). 128–131. 18 indexed citations
19.
Diamond, Henry D.. (1953). Recent Advances in the Management of Lymphomas and Leukemias. Medical Clinics of North America. 37(3). 843–867. 13 indexed citations
20.
Diamond, Henry D. & Lloyd F. Craver. (1951). Radioactive phosphorus. II. In the treatment of myeloid leukemia. Cancer. 4(5). 999–1008. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lloyd F. Craver Breakdown of academic impact, for papers by K.A. MacLennan Breakdown of academic impact, for papers by J. O. Armitage Breakdown of academic impact, for papers by Peter Bucsky Breakdown of academic impact, for papers by H Rubie Breakdown of academic impact, for papers by G Farrer-Brown Breakdown of academic impact, for papers by Milton H. Donaldson Breakdown of academic impact, for papers by Jillian R. Mann Breakdown of academic impact, for papers by Bertha A. Bouroncle Breakdown of academic impact, for papers by Ruth Heyn
Rankless by CCL
2026